The Insight Partners published latest research report on “Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Clinical Indication, Functionality, Application, End User”,
The Insight Partners published latest research report on “Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Clinical Indication, Functionality, Application, End User”, the global market size is projected to reach USD 12,245.04 million by 2028 from USD 7,825.38 million in 2021. The market is estimated to grow with a CAGR of 6.6% from 2022 to 2028.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00003534
Growth Strategies by the Key Players Operating in the Pharmaceutical Excipients Market:
July-2022: Roquette Freres SA announced addition of a new grade to its PEARLITOL SD mannitol range for direct compression – PEARLITOL 150 SD. Developed specifically for active pharmaceutical ingredients (APIs) that are highly sensitive to reducing sugars, PEARLITOL 150 SD supports opportunities to unlock advanced tablet dosage forms – even when using challenging active ingredients.
May-2022: Avantor announced that it will establish a new manufacturing and distribution hub in Singapore by integrating its existing distribution facility with new manufacturing operations. The new hub brings Avantor services closer to regional customers and strengthens global supply chain capabilities. The facility will be fully operational early next year.
Pharmaceutical excipients are substances other than active pharmaceutical ingredients (APIs) that have been appropriately evaluated for safety and are intentionally included in a drug delivery system.
Impact of COVID-19 Pandemic on Global Pharmaceutical Excipients Market:
The global supply chain of medicines was under pressure during the COVID-19 pandemic because of a deficit of raw materials such as active pharmaceutical ingredients (APIs) and excipients. According to the Council on Foreign Relations, a large share of the medicines sold in the US are produced in China and India, while these two countries meet almost 80% of the US API demand. As one of the world’s largest producers of generic medicines (producing 20% of global generics supply), India imports almost 70% of its APIs from China; therefore, disruption in its supply chain has resulted in drug supply shortages. In the likely and best-case scenarios, the effects of disruptions on pharmaceutical production and consequently on excipient demand caused by lockdowns and travel and transport bans across various countries, especially in the US, are relatively short-term. There is a rise in the discovery of clinical drugs for COVID-19, which caused growth in the pharmaceutical excipient market. However, the supply disruptions due to extended lockdowns in various countries was substantially impacted oral solid dosage drug manufacturing and, in turn, significantly impacted the demand growth of excipients worldwide.
Directly Purchase Premium Copy of Pharmaceutical Excipients Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00003534
Global Pharmaceutical Excipients Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 7,825.38 Million in 2021 |
| Market Size Value by | USD 12,245.04 Million by 2028 |
| Growth rate | CAGR of 6.6% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
| No. of Pages | 570 |
| No. of Tables | 662 |
| No. of Charts & Figures | 127 |
| Historical data available | Yes |
| Segments covered | Type, Clinical Indication, Functionality, Application, End User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | JRS PHARMA GmbH & Co KG, Roquette Freres SA, BASF SE, Evonik Industries AG, AshLand Inc, Archer-Daniels-Midland Co, The Dow Chemical Co, The Lubrizol Corp, Avantor Inc, MEGGLE GmbH & Co KG., Univar Solutions Inc. |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 570 pages with 662 list of tables & 127 list of figures from the report, “Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Bioresorbable Polymers, Lipids, and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins, Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent & Coating Agent; Sweetener & Flavoring Agents; Suspending & Viscosity Agents; Preservative & Controlled-Release; Antioxidant & Oil; Tablet Filler & Diluents; Binders, Compression Aids, and Granulating Agents; and Others), Application (Parenteral, Oral Formulations & Tablets, Capsules, Liquid & Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals & OTC, Topical, and Others), End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/pharmaceutical-excipients-market
Product Developments:
The pharmaceutical excipients market is characterized by the presence of large and small market players. A few product launches related to pharmaceutical excipients are mentioned below:
In October 2022, Rouqette, a pharmaceutical and nutraceutical excipients provider, launched two next-generation mannitol products—PEARLITOL CR-H and PEARLITOL 200 GT— for direct compression. These excipients have been specially formulated to overcome the unique drug formulation challenges in the pharmaceutical spaces, which helps the manufacturers optimize direct compression processes and expand into application areas such as mini tabs and controlled-release tablets.
In March 2022, Lubrizol Life Science Health launched Apisolex, a novel solubility-enhancing excipient for parenteral drug products. With the ability to improve solubility by up to 50,000-fold and support high drug loading, Apisolex excipient provides access to new and improved parenteral drug products. This is especially relevant in oncology, as direct injection of drugs into the bloodstream ensures higher bioavailability and lower patient variability compared to oral delivery.
In November 2021, Gattefosse, a France-based company that designs and produces pharmaceutical excipients, launched three new pharmaceutical excipients—Labrefac MC60, Gelucire 59/14, and Emulfree Duo. Labrefac MC60 and Gelucire 59/14 excipients are used for the oral administration route drugs, whereas Emulfree Duo is used for the topical administration route drugs.
In August 2021, SPI Pharma, a US-based company, introduced Ultrabust, an excipient platform for flash orally disintegrating tablets (ODTs). The use of Ultrabust excipient in an ODT formulation facilitates the disintegration of the tablet in under 10 seconds.
In April 2021, DFE Pharma, the pharmaceutical excipient solution provider, launched its new product line, BioHale, a solution for biopharmaceutical manufacturers. With the launch of BioHale Sucrose, DFE Pharma offers exceptional market purity and low endotoxin excipient to be used in the formulation.
The active participation of market players in product innovation and development leading to the increase in product launches fuels the growth of the pharmaceutical excipients market.
According to Food and Drug Administration (FDA), in the US, about 9 out of the 10 prescriptions have generic drugs. Governments of developing countries are focusing on reducing healthcare costs by boosting the production of generic drugs. For instance, in November 2008, the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India launched Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) to make quality generic medicines available at affordable prices. The scheme focused on dedicated outlets known as Janaushadhi Kendras, offering generic medicines at affordable prices. Till 2021, 8,012 Janaushadhi Kendras were functional across India. In addition, many drugs are on the brink of losing their patents. Generic drug companies can produce replicas of branded drugs when patents of original drugs expire. The replicas can cost up to 80% less than the originals. Therefore, the generics industry has witnessed remarkable growth in the last decade as the patents of many branded drugs have expired, with companies achieving above-average shareholder returns.
The Parenteral Drug Association (PDA), Centers for Disease Control and Prevention (CDC), Office of Pharmaceutical Quality (OPQ), World Health Organization (WHO), and European Federation of Pharmaceutical Industries and Association (EFPIA) are a few of the major primary and secondary sources referred to while preparing the report on the pharmaceutical excipients market.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Excipients Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Nutraceutical Excipients Market Forecast to 2028 - Covid-19 Impact and Global Analysis
Binders Excipients Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Glucose Excipient Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Cellulose Derivatives Excipient Market Forecast to 2028 - Covid-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/pharmaceutical-excipients-market